Maravai LifeSciences Holdings, Inc. operates through a portfolio of specialized brands, including TriLink BioTechnologies, Cygnus Technologies, Glen Research, and Alphazyme. The company's core offerings include complex nucleic acids for mRNA vaccines and therapeutics, featuring its proprietary CleanCap technology for mRNA capping. Additionally, Maravai provides custom enzymes for research and diagnostic use, as well as antibody-based products to detect impurities during the production of biopharmaceuticals. By supplying essential reagents and consumables, the company supports its customers from early-stage discovery through clinical development and commercial manufacturing.
